Antimicrobial susceptibility trends in Campylobacter jejuni and Campylobacter coli isolated from a rural Egyptian pediatric population with diarrhea. 2003

Shannon D Putnam, and Robert W Frenck, and Mark S Riddle, and Atef El-Gendy, and Nancy N Taha, and Brian T Pittner, and Remon Abu-Elyazeed, and Thomas F Wierzba, and Malla R Rao, and Stephen J Savarino, and John D Clemens
Enteric Disease Research Program, Naval Medical Research Center, Silver Spring, MD, USA. putnams@nmrc.navy.mil

Comparative and trend analysis was conducted on annual prevalence of antimicrobial susceptibility among Campylobacter jejuni and Campylobacter coli recovered from rural Egyptian children from 1995 through 2000. C. jejuni and C. coli demonstrated significant decreasing trends in ciprofloxacin susceptibility over the study period (p < 0.001 for both). In general, C. coli demonstrated a higher degree of susceptibility than C. jejuni, however, there was no statistical difference (p = 0.2) comparing the linear trends over the duration of the study. There was no indication of frank macrolide (erythromycin or azithromycin) resistance among any Campylobacter. Moreover, there were statistically significant positive trends in both the MIC(50) and MIC(90) values for the erythromycin and azithromycin during the study period, suggesting a possible decreasing trend in susceptibility among Campylobacter. This study demonstrated that antimicrobial susceptibility in Campylobacter has significantly decreased from 1995 through 2000 among pediatric diarrhea cases in rural Egypt.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010372 Pediatrics A medical specialty concerned with maintaining health and providing medical care to children from birth to adolescence.
D011336 Probability The study of chance processes or the relative frequency characterizing a chance process. Probabilities
D002169 Campylobacter Infections Infections with bacteria of the genus CAMPYLOBACTER. Campylobacter Infection,Campylobacteriosis,Infections, Campylobacter,Campylobacterioses,Infection, Campylobacter
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D003967 Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. Diarrheas

Related Publications

Shannon D Putnam, and Robert W Frenck, and Mark S Riddle, and Atef El-Gendy, and Nancy N Taha, and Brian T Pittner, and Remon Abu-Elyazeed, and Thomas F Wierzba, and Malla R Rao, and Stephen J Savarino, and John D Clemens
March 2005, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Shannon D Putnam, and Robert W Frenck, and Mark S Riddle, and Atef El-Gendy, and Nancy N Taha, and Brian T Pittner, and Remon Abu-Elyazeed, and Thomas F Wierzba, and Malla R Rao, and Stephen J Savarino, and John D Clemens
August 1993, Zentralblatt fur Bakteriologie : international journal of medical microbiology,
Shannon D Putnam, and Robert W Frenck, and Mark S Riddle, and Atef El-Gendy, and Nancy N Taha, and Brian T Pittner, and Remon Abu-Elyazeed, and Thomas F Wierzba, and Malla R Rao, and Stephen J Savarino, and John D Clemens
November 1984, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Shannon D Putnam, and Robert W Frenck, and Mark S Riddle, and Atef El-Gendy, and Nancy N Taha, and Brian T Pittner, and Remon Abu-Elyazeed, and Thomas F Wierzba, and Malla R Rao, and Stephen J Savarino, and John D Clemens
April 2022, Foodborne pathogens and disease,
Shannon D Putnam, and Robert W Frenck, and Mark S Riddle, and Atef El-Gendy, and Nancy N Taha, and Brian T Pittner, and Remon Abu-Elyazeed, and Thomas F Wierzba, and Malla R Rao, and Stephen J Savarino, and John D Clemens
November 2008, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Shannon D Putnam, and Robert W Frenck, and Mark S Riddle, and Atef El-Gendy, and Nancy N Taha, and Brian T Pittner, and Remon Abu-Elyazeed, and Thomas F Wierzba, and Malla R Rao, and Stephen J Savarino, and John D Clemens
January 1990, Microbiologica,
Shannon D Putnam, and Robert W Frenck, and Mark S Riddle, and Atef El-Gendy, and Nancy N Taha, and Brian T Pittner, and Remon Abu-Elyazeed, and Thomas F Wierzba, and Malla R Rao, and Stephen J Savarino, and John D Clemens
June 1987, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology,
Shannon D Putnam, and Robert W Frenck, and Mark S Riddle, and Atef El-Gendy, and Nancy N Taha, and Brian T Pittner, and Remon Abu-Elyazeed, and Thomas F Wierzba, and Malla R Rao, and Stephen J Savarino, and John D Clemens
January 2023, Frontiers in microbiology,
Shannon D Putnam, and Robert W Frenck, and Mark S Riddle, and Atef El-Gendy, and Nancy N Taha, and Brian T Pittner, and Remon Abu-Elyazeed, and Thomas F Wierzba, and Malla R Rao, and Stephen J Savarino, and John D Clemens
September 1984, Antimicrobial agents and chemotherapy,
Shannon D Putnam, and Robert W Frenck, and Mark S Riddle, and Atef El-Gendy, and Nancy N Taha, and Brian T Pittner, and Remon Abu-Elyazeed, and Thomas F Wierzba, and Malla R Rao, and Stephen J Savarino, and John D Clemens
June 1983, Laboratory animal science,
Copied contents to your clipboard!